Investigation into Tandem Diabetes Care: Potential Securities Fraud Claims Emerged
Pomerantz Law Firm Investigates Tandem Diabetes Care, Inc.
Pomerantz LLP, a distinguished law firm with a reputation for handling securities class actions, has announced that it is investigating potential claims on behalf of investors in Tandem Diabetes Care, Inc. (NASDAQ: TNDM). This inquiry follows troubling reports that the company may have engaged in securities fraud or other illegal business practices.
On August 7, 2025, Tandem issued a critical public disclosure indicating that certain models of its insulin pumps were found to have a malfunction. This issue, described as a
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.